Analogues are not only easier to use, but also allow for regimens and therapies (such as insulin pump therapy) that somewhat improve life expectancy and signifi

Analogues are not only easier to use, but also allow for regimens and therapies (such as insulin pump therapy) that somewhat improve life expectancy and significantly improve quality of life. The relatively inelastic demand of insulin analogues when synthetic human insulin is available shows how important analogues are to T1 diabetics. Sometimes pharma companies try to allude to analogues being a luxury good compared to synthetic human insulin. But to T1 diabetics this notion is generally ridiculous. Analogue insulins allow them to regain a little bit more quality of life lost to the disease, and that should be a human right when insulin manufacturing costs are so low.